TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy by Johnson, William T., Ganesan, Nivetha, Epstein-Peterson, Zachary D., Moskowitz, Alison J., Stuver, Robert N., Maccaro, Catherine R., Galasso, Natasha, Chang, Tiffany, Khan, Niloufer, Aypar, Umut, Lewis, Natasha E., Zelenetz, Andrew D., Palomba, M. Lia, Matasar, Matthew J., Noy, Ariela, Hamilton, Audrey M., Hamlin, Paul, Caron, Philip C., Straus, David J., Intlekofer, Andrew M., Lee Batlevi, Connie, Kumar, Anita, Owens, Colette N., Sauter, Craig S., Falchi, Lorenzo, Lue, Jennifer K., Vardhana, Santosha A., Salles, Gilles, Dogan, Ahmet, Schultz, Nikolaus D., Arcila, Maria E., Horwitz, Steven M.

Get full text

TP53 Mutations Identify High-Risk Peripheral T-Cell Lymphoma Patients Treated with CHOP-Based Chemotherapy by Johnson, William T., Ganesan, Nivetha, Epstein-Peterson, Zachary D., Maccaro, Catherine, Galasso, Natasha, Sauter, Craig S., Neuman, Rachel, Khan, Niloufer, Moskowitz, Alison J., Dogan, Ahmet, Horwitz, Steven M.

Get full text

Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma by Moskowitz, Alison, Advani, Ranjana H., Ganesan, Nivetha, Chang, Tiffany, Hancock, Helen, Davey, Theresa, Miller, Tayler, Gibaldi, Angela, Smith, Marcel, Assini, Alicia, Sarmasti, Lisa, Collins, Paige, Patel, Suviasini, Le, Andrew K.N, Maccaro, Catherine, Casper, Ellie, Galasso, Natasha, Subzwari, Sarima, Jihad, Marwah, Ghione, Paola, Hoppe, Richard T., Imber, Brandon S., Johnson, William T., Owens, Colette, Vardhana, Santosha A., Schoder, Heiko, Yahalom, Joachim, Horwitz, Steven

Get full text